Management Change31 March 2026 at 03:31 pm
Alembic Pharmaceuticals' Head - Formulation Business Development Resigns
AI Summary
Alembic Pharmaceuticals Ltd. has announced the resignation of Mr. Nilesh Wadhwa, Head - Formulation Business Development. The resignation is effective from 31st March, 2026 (after closure of business hours). The company has disclosed the details as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Highlights
- Mr. Nilesh Wadhwa has resigned from his position as Head - Formulation Business Development at Alembic Pharmaceuticals Ltd.
- His resignation is effective from 31st March, 2026 (after closure of business hours).
- The company has disclosed the details as required under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- Mr. Wadhwa's resignation is in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
- The company has attached the intimation of resignation and the details required under the SEBI regulations as 'Annexure-B' and 'Annexure-A' respectively.